Climb Bio, Inc.
CLYM
$1.21
-$0.02-1.63%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -92.98M | -73.90M | -69.12M | -64.20M | -14.53M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 57.54M | 56.64M | 56.69M | 54.02M | 1.70M |
| Change in Net Operating Assets | 6.27M | 1.70M | 1.45M | 10.23M | 5.58M |
| Cash from Operations | -29.18M | -15.56M | -10.99M | 57.00K | -7.24M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -4.65M | -4.65M | -4.65M | -4.65M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -172.95M | -116.45M | -26.29M | 73.54M | 76.94M |
| Cash from Investing | -177.59M | -121.09M | -30.94M | 68.89M | 76.94M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 130.96M | 130.98M | 130.98M | 129.23M | 855.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -250.00K | -250.00K | -- | -- | -- |
| Cash from Financing | 130.71M | 130.73M | 130.98M | 129.23M | 855.00K |
| Foreign Exchange rate Adjustments | 46.00K | 42.00K | -231.00K | -335.00K | 45.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -76.01M | -5.88M | 88.82M | 197.85M | 70.59M |